In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.

In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.

INTRODUCTION: Trastuzumab, a humanized antibody directed against the Her2 receptor, induces the expression of p27(kip1), an intranuclear cyclin-dependent kinase inhibitor in some breast cancer cells. The aim of this study was to develop a radioimmunoconjugate (RIC) to monitor trastuzumab-induced p27...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Cornelissen, B, Kersemans, V, McLarty, K, Tran, L, Vallis, K, Reilly, R
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2009

Míreanna comhchosúla

The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2008)

111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2009)

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
de réir: McLarty, K, et al.
Foilsithe / Cruthaithe: (2009)

Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
de réir: Costantini, D, et al.
Foilsithe / Cruthaithe: (2008)

Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts.
de réir: Costantini, D, et al.
Foilsithe / Cruthaithe: (2010)

(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.
de réir: Costantini, D, et al.
Foilsithe / Cruthaithe: (2007)

Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
de réir: Caroline Chung, et al.
Foilsithe / Cruthaithe: (2009-01-01)

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
de réir: McLarty, K, et al.
Foilsithe / Cruthaithe: (2009)

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer
de réir: Caroline Muñoz, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Chemotherapy-induced cardiotoxic effect in breast cancer patients treated with trastuzumab (Herceptin) by MRI
de réir: Mohamed Aboulfotouh Mourad, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2008)

Biodistribution and nuclear import of 111In-labeled HIV-1 tat peptide immunoconjugates after intravenous or intratumoural injection in tumour-bearing mice
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2006)

The importance of antibody dependent cell-mediated cytotoxicity (ADCC) for breast cancer response to trastuzumab - Herceptin
de réir: Juranić Zorica D., et al.
Foilsithe / Cruthaithe: (2002-01-01)

Recommendations for Management of the Trastuzumab (Herceptin) among Iranian Breast Cancer Patients, A Policy Brief
de réir: Mohammad Reza Rouhollahi, et al.
Foilsithe / Cruthaithe: (2014-04-01)

Validation of ELISA Test-system for Trastuzumab (Herceptin, Hertikad) quantitative determination in biological fluids
de réir: V. V. Pisarev, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
de réir: Florence R. Wilson, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
de réir: Brunet Joan, et al.
Foilsithe / Cruthaithe: (2007-05-01)

Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2007)

Kinetics of internalization and nuclear import and efflux of 111In-and 123I-labeled HIV-1 tat-peptide immunoconjugates (IC's) in BT-474 human breast cancer cells
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2006)

In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin
de réir: Soudabeh Akbarzadeh-Sharbaf, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
de réir: Florence R. Wilson, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Plant-made trastuzumab (herceptin) inhibits HER2/Neu+ cell proliferation and retards tumor growth.
de réir: Tatiana V Komarova, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice
de réir: Yousif Nasser, et al.
Foilsithe / Cruthaithe: (2011-10-01)

Prática de clínica dos enfermeiros portugueses: administração subcutânea de trastuzumab (herceptin®) e rituximab (mabthera®)
de réir: Alice Monteiro, et al.
Foilsithe / Cruthaithe: (2018-06-01)

A preliminary study to establish the transfected CHO cell lines which highly express Trastuzumab - A biosimilar product of Herceptin
de réir: Nguyen Quang Huy, et al.
Foilsithe / Cruthaithe: (2022-11-01)

A model system to explore the detection limits of antibody-based immuno-SPECT imaging of exclusively intranuclear epitopes
de réir: Veal, M, et al.
Foilsithe / Cruthaithe: (2021)

Ultrasound-triggered herceptin liposomes for breast cancer therapy
de réir: Amal Elamir, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Effect of recombinant Herceptin on the growth of breast cancer cells
de réir: Nafiseh Kiarostami, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
de réir: Volkmar Müller, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
de réir: Kong Sun-Young, et al.
Foilsithe / Cruthaithe: (2008-10-01)

Herceptin resistance in HER2-moderately expressed breast cancer
de réir: Kerry, J, et al.
Foilsithe / Cruthaithe: (2012)

Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
de réir: Costantini, D, et al.
Foilsithe / Cruthaithe: (2010)

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.
de réir: Fredersdorf, S, et al.
Foilsithe / Cruthaithe: (1997)

Cell penetrating peptides for in vivo molecular imaging applications.
de réir: Kersemans, V, et al.
Foilsithe / Cruthaithe: (2008)

Regulation of p27<sup>Kip1</sup> and p57<sup>Kip2</sup> Functions by Natural Polyphenols
de réir: Gian Luigi Russo, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial
de réir: Naveen Reddy, et al.
Foilsithe / Cruthaithe: (2024-03-01)

An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
de réir: Qing Chen, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Screening For Small Molecule Inhibitors Of p27Kip1 Degradation
de réir: Ooi, Li Ching
Foilsithe / Cruthaithe: (2012)

p27KIP1 Deletions in Childhood Acute Lymphoblastic Leukemia
de réir: Hiroaki Komuro, et al.
Foilsithe / Cruthaithe: (1999-08-01)

p27kip1 at the crossroad between actin and microtubule dynamics
de réir: Gian Luca Rampioni Vinciguerra, et al.
Foilsithe / Cruthaithe: (2019-04-01)